Patent details
LUC00307 Product Name: Loncastuximab tesirine sous toutes ses formes protégées par le brevet de base
Basic Information
- Publication number:
- LUC00307
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP137858312
- Legal Status:
- Inactive
- Application number:
- LUC00307
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1695
- Marketing Authorization Type:
- Marketing Authorization Date:
- 22/12/2022
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 10/05/2023
- First Marketing Authorization date:
- 22/12/2022
- Grant date:
- 22/09/2025
- Activation date:
- Publication date:
- 11/05/2023
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 22/12/2037
- SPC Extension Expiration:
- 22/12/2037
- Rejection date:
- Withdrawal date:
Owner
- From:
- 10/05/2023
- Name:
- ADC Therapeutics SA
- Address:
- Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)
- Name:
- Medimmune Limited
- Address:
- Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 10/05/2023
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/07
- Publication date:
- 06/06/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/11
- Publication date:
- 02/10/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/10/2033
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 10/05/2023 | MA publication | 12 |
| 10/05/2023 | Application Form | 3 |
| 10/05/2023 | Marketing authorization | 4 |
| 10/05/2023 | Summary of the product caracteristics | 36 |
| 11/05/2023 | Outgoing Correspondence | 1 |
| 11/05/2023 | Publication | 1 |
| 22/09/2025 | Publication | 1 |
| 22/09/2025 | Certificate | 1 |
| 22/09/2025 | Outgoing Correspondence | 1 |